NASDAQ
10.04.26 | 21:59
5,940 US-Dollar
-8,47 % -0,550
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.04. | Profound Medical Corp.: Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting | 1 | GlobeNewswire (USA) | ||
| 27.03. | Profound Medical Corp (2): Profound talks up Tulsa procedure milestone in Texas | 3 | Stockwatch | ||
| 27.03. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.03. | Profound Medical Corp.: Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone | 2 | GlobeNewswire (USA) | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 16.03. | Profound Medical: Raymond James bestätigt "Outperform"-Rating nach starken Studiendaten | 1 | Investing.com Deutsch | ||
| 16.03. | Profound Medical stock rating reiterated by Raymond James on trial data | 2 | Investing.com | ||
| 13.03. | Profound Medical Corp.: CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence | 1 | GlobeNewswire (USA) | ||
| 13.03. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Profound Medical Corp (2): Profound to discuss Captain trial results March 13 | 14 | Stockwatch | ||
| 06.03. | Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026 | 4 | Seeking Alpha | ||
| 05.03. | Profound Medical Q4 Earnings Assessment | 1 | Benzinga.com | ||
| 05.03. | Profound Medical Corp. - 10-K, Annual Report | 2 | SEC Filings | ||
| 05.03. | Profound Medical GAAP EPS of $0.27 beats by $0.55, revenue of $6M misses by $1.72M | 1 | Seeking Alpha | ||
| 05.03. | Profound Medical Corp. Q4 Profit Climbs | 1 | RTTNews | ||
| 05.03. | Earnings Summary: Profound Medical Q4 | 1 | Benzinga.com | ||
| 05.03. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.03. | Profound Medical's Earnings: A Preview | 2 | Benzinga.com | ||
| 12.02. | Profound Medical Corp. - 8-K, Current Report | 4 | SEC Filings | ||
| 06.02. | Profound Medical Corp (2): Profound sees Polish hospital complete 500th procedure | 1 | Stockwatch | ||
| 05.02. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings |
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROGYNY | 16,300 | -1,39 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BILLIONTOONE | 81,13 | -1,65 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,510 | -4,07 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| BRIGHTSPRING HEALTH SERVICES | 45,330 | -1,33 % | BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 | ||
| SIEMENS HEALTHINEERS | 37,170 | -0,46 % | ANALYSE-FLASH: Goldman senkt Ziel für Siemens Healthineers - 'Neutral' | NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| HEARTFLOW | 26,980 | -0,37 % | Stifel reiterates Heartflow stock rating on clinical data strength | ||
| TALKSPACE | 5,170 | +0,10 % | Universal Health Services, Inc. to Acquire Talkspace, Inc. | Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care KING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal... ► Artikel lesen | |
| BETA BIONICS | 8,880 | -7,79 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,750 | -0,72 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FRESENIUS | 44,250 | -0,56 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| GENEDX | 59,65 | -0,67 % | Cathie Wood's ARK sells BWX Technologies stock, buys GeneDx | ||
| PRIVIA HEALTH GROUP | 22,370 | -1,50 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| PROCEPT BIOROBOTICS | 23,150 | -0,47 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| CLEARPOINT NEURO | 8,680 | -3,12 % | ClearPoint Neuro, Inc.: ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 | SOLANA BEACH, CA / ACCESS Newswire / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,720 | +0,78 % | AKTIE IM FOKUS: Carl Zeiss Meditec erholt - Goldman Sachs verhalten optimistsich | FRANKFURT (dpa-AFX) - Nach verhalten optimistischen Aussagen von Goldman Sachs zu Carl Zeiss Meditec hat die Aktie am Dienstag einen Erholungsversuch unternommen. Am Vormittag ging es um gut drei Prozent... ► Artikel lesen |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 5,940 Euro und damit -8,47 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.